Literature DB >> 28600047

Maternal outcome after conservative management of abnormally invasive placenta.

Hsiu-Wei Su1, Yu-Chiao Yi1, Jenn-Jhy Tseng1, Wei-Chih Chen1, Ya-Fang Chen1, Hsiao-Fan Kung1, Min-Min Chou2.   

Abstract

OBJECTIVE: The purpose of this study was to describe our preliminary experience of the efficacy and safety of a conservative strategy for abnormally invasive placenta.
MATERIALS AND METHODS: A retrospective review of eight pregnant women with abnormally invasive placenta (one with placenta previa accrete, three with placenta previa increta, and four with previa percreta) was performed. The diagnosis was made by prenatal ultrasonography, and was confirmed by operative and histopathological findings. Patients who desired future fertility or who had extensive diseases were selected as candidates after panel meeting. Conservative management after obtaining informed consent was defined by a primary cesarean delivery before 35 weeks of gestation with the abnormally adherent placenta left in situ, partially or totally. The primary outcome was successful uterine preservation. The secondary outcome was severe maternal morbidity including sepsis, coagulopathy, immediate or delayed hemorrhage bladder injury, and fistula.
RESULTS: Among the eight patients, the mean age was 34 ± 3 years (range, 30-40 years). All women had risk factors, such as placental previa, previous cesarean delivery and/or dilation & curettage, for abnormally invasive placenta. Seven women underwent planned cesarean delivery at the mean gestation age of 34 weeks (range, 31-37 weeks). One woman received hysterotomy at 18 weeks. In our series, the uterus was preserved in only two cases (25%), one who received hysterotomy at a relatively young gestational age and another who had mild disease. Mean maternal blood loss during primary cesarean delivery was 528 ± 499 ml (range, 100 ml-1,500 ml). Severe maternal morbidity was recorded in seven out of eight patients (87.5%).
CONCLUSION: In this small series, we observed a low successful uterine preservation rate and a high maternal complication rate. We recommend that primary cesarean hysterectomy should be used as the treatment of choice for mild to severe abnormally invasive placenta. Conservative management should be reserved for women with a strong fertility desire and women with extensive disease that precludes primary hysterectomy due to surgical difficulty.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Abnormally invasive placenta; Conservative treatment; Morbidly adherent placenta; Placental accreta; Uterine preservation

Mesh:

Year:  2017        PMID: 28600047     DOI: 10.1016/j.tjog.2017.04.016

Source DB:  PubMed          Journal:  Taiwan J Obstet Gynecol        ISSN: 1028-4559            Impact factor:   1.705


  6 in total

Review 1.  Risk of Subsequent Hysterectomy after Expectant Management in the Treatment of Placenta Accreta Spectrum Disorders.

Authors:  Anca Maria Panaitescu; Gheorghe Peltecu; Radu Botezatu; George Iancu; Nicolae Gica
Journal:  Medicina (Kaunas)       Date:  2022-05-19       Impact factor: 2.948

2.  Ovarian reserve after uterine artery embolization in women with morbidly adherent placenta: A cohort study.

Authors:  Aya Mohr-Sasson; Maya Spira; Rony Rahav; Dafna Manela; Eyal Schiff; Shali Mazaki-Tovi; Raoul Orvieto; Eyal Sivan
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

3.  Successful conservative treatment of multiorgan infiltrating placenta percreta by uterine embolization and followup with serial magnetic resonance. A case report.

Authors:  Ebtehaj Alshammary; Mohamed Fawaz Elmuzaini
Journal:  Int J Surg Case Rep       Date:  2019-04-16

4.  Diagnosis of Interventional Transvaginal Maternal Diseases Based on Color Doppler Ultrasound.

Authors:  Canliang Wen; Lan Huang; Hongye Jiang
Journal:  J Healthc Eng       Date:  2021-04-01       Impact factor: 2.682

5.  Obstetrical outcome in the third trimester after hysteroscopic adhesiolysis.

Authors:  Qing Feng; Bingsi Gao; Huan Huang; Jeffrey Je-Chuen Woo; Lingxiao Zou; Xingping Zhao; Chunxia Cheng; Dabao Xu
Journal:  Ann Transl Med       Date:  2020-02

6.  Conservative management of abnormally invasive placenta complicated by local hyperfibrinolysis and beginning disseminated intravascular coagulation.

Authors:  C Biele; L Kaufner; A Schwickert; A Nonnenmacher; K von Weizsäcker; M Z Muallem; W Henrich; T Braun
Journal:  Arch Gynecol Obstet       Date:  2020-08-18       Impact factor: 2.344

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.